FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancerPRNewsWire • 04/22/21
Vectura confirms GlaxoSmithKline patent litigation is over, notes Hikma's launch of generic Advair DiskusProactive Investors • 04/21/21
GlaxoSmithKline biopharma spinoff to deliver solid sales growth contrary to market scepticism, says City brokerProactive Investors • 04/19/21
GlaxoSmithKline Surges On Report Activist Investor Takes 'Significant' StakeInvestors Business Daily • 04/15/21
London Markets: GlaxoSmithKline shares surge on report Elliott Management building a stakeMarket Watch • 04/15/21
EXCLUSIVE: GlaxoSmithKline's vaccine R&D chief is departing for microbiome upstart ViomeBusiness Insider • 04/15/21
How Important Is Novavax's COVID Vaccine Manufacturing Deal With GlaxoSmithKline?The Motley Fool • 04/10/21
Which Stock Is Likely to Be the Biggest Winner: Lilly, Vir, or GlaxoSmithKline?The Motley Fool • 04/10/21